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Abstract
Mycobacterium avium subsp. paratuberculosis (MAP) infection is highly spread in the ruminant herds of Sardinia, in the
Western Mediterranean. The objective of this study was to investigate prevalence of MAP infection in association with
Multiple Sclerosis (MS) using clinical specimen from patients and controls. We analyzed samples for the presence of MAP
specific DNA and to demonstrate humoral response to a MAP protein (MAP2694), a predicted homologue of the T-cell
receptor gamma-chain/complement component 1 of the host. We found presence of MAP DNA in 42% of the MS patients
and an extremely significant humoral immune response revealed by the MS patients against the MAP protein. In our
opinion, this is the first report that significantly associates MAP infection with MS. Further studies will be required to confirm
if MAP could be one of the triggers of MS, according to the molecular mimicry theory, in susceptible (and genetically at risk)
individuals.
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Introduction
Multiple sclerosis (MS) is a chronic, autoimmune and
demyelinating syndrome that primarily affects the central nervous
system. MS is characterized by the infiltration of myelin-epitope–
specific CD4+ T cells [1] that attack constituents of the axonal
myelin sheath and other elements of the central nervous system
(CNS), destroying myelin and the basal axon. Moreover, cd T cells
play a role in the development and potentially the progress of the
demyelinating CNS inflammation [2].
The etiology of MS is largely elusive, although it is commonly
believed to be caused by the joint action of several, largely
unknown, genetic factors and susceptibility variants in the
presence of other unidentified, permissive/triggering environmen-
tal agents. Among the non-heritable causative factors hypothesized
to be involved in MS etiology and pathogenesis is MAP, a
potentially infective, obligate pathogenic bacillus of the genus
Mycobacterium that causes Johne’s disease in ruminants and it is
associated to a human form of the enteropathy called Crohn’s
disease (CD) [3]; more recently, it was linked to type 1 diabetes
mellitus (T1DM) [4]. Polymorphisms in the natural resistance-
associated macrophage protein gene (SLC11A1,e xNRAMP1) have
previously been found to be associated with mycobacterial
infections as well as CD, T1DM and MS [4,5,6]. NRAMP1 is
an iron transporter associated with macrophage activation. This
gene has multiple pleiotropic effects on macrophage function,
including regulation of cytokine production, tumor necrosis factor
a, interleukin-1 b, inducible nitric oxide synthase and regulation of
major histocompatibility complex class II expression and antigen
presentation functions [7,8]. All of these activities are not only
essential for protection against mycobacterial infection (innate
defenses), but also critically involved in the induction and
progression of autoimmune diseases [5,7,8].
MS distribution in Europe follows a north-south gradient, with the
notable exception of the Mediterranean island of Sardinia, which has
one of the highest prevalence worldwide together with a reportedly
high incidence of T1DM [5,9]. These data suggest that T1DM and
MS might be triggered by a common environmental/infectious agent
in Sardinia and that its population could be a suitable target to
explore because of their genetic peculiarity which might have been
shaped over time as a function of strict isolation and consequent
endogamy, consanguinity and the burden of historical scourges such
as Malaria. High resolution, population based analyses are required
to ascertain or negate any role of the unique Sardinian haplotypes
and the high incidence of the autoimmune diseases.
In view of the above and since molecular mimicry between
human and MAP proteins was postulated as a mechanism for
Crohn’s disease and T1DM [4,9,10], we wanted to look for the
presence of MAP in MS patients by PCR and/or immunoassays
against MAP2694, which is a transmembrane glycine and proline
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ceae family.
Materials and Methods
Subjects
A total of 50 MS patients [28 females & 22 males (F/M:1.2/1);
42 relapsing-remitting, 6 secondary progressive, 2 primary
progressive - actual age=44.5 (SD+/211.25), age at onset=30.4
(SD+/29.9), disease duration from onset=14.1 (SD+/211.6)]
and 56 ethnically and demographically similar healthy controls
[30 females & 26 males (F/M: 1.1), actual age=47.7 (SD+/
212.7), including people related to patients such as friends and
spouses but not direct relatives] were enrolled in the study. No
statistically significant differences with respect to gender, age and
descent were observed among patients and healthy groups. All
the patients had clinically definite MS according to the
McDonald Criteria (version 2005) [11] and were free from any
immunomodulating or immunosuppressive drugs for at least 6
months.
Ethical statement
Blood samples were collected after obtaining informed written
consents from all subjects. The study protocols were approved by
the ethics committee of the University of Cagliari, Sardinia, Italy.
IS900 MAP PCR
The presence of MAP specific DNA was ascertained by
observing IS900 specific amplicons after PCR was performed as
described previously [3].
MAP 2694 Cloning and Expression
Specific primers were designed to amplify MAP2694 from the
genome of MAP strain ATCC43015. The amplified fragment of
1056 bp was inserted into the pMAL-c2x vector between BamH1
Table 1. ELISA and MAP-PCR results.
MAP2694 antibody- positive MAP2694 antibody-negative IS900PCR + IS900PCR 2
MS patients (n=50) 16(32%) 34(68%) 21(42%) 29(58%)
Healthy controls (n=56) 1(2%) 55(98%) 7(12%) 49(87%)
Total 17 89 28 78
Antibody positive patients were so identified by selecting a cut-off OD value of 0.84 (as calculated by the mean plus two times the standard deviation of the mean).
doi:10.1371/journal.pone.0018482.t001
Figure 1. Blast alignments with masking-off segments of the query sequence that have low compositional complexity. Results show
region of identity, strongly similar amino acids with a plus (+) and missing region in dashes (–). Query sequence is MAP2694.
doi:10.1371/journal.pone.0018482.g001
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transform E. coli K12 TB1cells. After induction with IPTG, the
expressed protein was purified with three column purification steps
for each extraction. A specific fraction corresponding to our
recombinant/fusion protein(s), at the level of 78.5 kDa, was
observed on the SDS-PAGE gel. This was in agreement with the
expected collective molecular mass of the fusion proteins [maltose
binding protein (MBP) (42.5 kDa) and MAP2694 (36 kDa].
Western blotting confirmed that the protein was recognized by
human sera (that were tested positive to previously expressed MAP
proteins) indicating that the purified protein could be used as an
antigen for immuno-diagnostic tests (see results).
ELISA
The immunological screening was performed by ELISA
wherein all assays were performed in replicates as previously
reported [4] and the results were expressed as means 6 standard
error of the mean. For the sake of negative control, ELISA assays
using the E. coli extracts containing the vector without the insert
and expressing only the MBP were performed. No reaction was
observed [optical density (OD) values were under 0.2 in both MS
patients and controls]. All values were checked for significance by
the Chi-Square test with Yate’s corrections. ELISA performance
was also assessed by the area under the receiver operating
characteristic curve (AUC-ROC).
Results
A total of 21 out of 50 MS patients were observed positive by
PCR (42%) based on the amplification of IS900, a specific
signature element within the genome of MAP, whereas, only 7 out
of 56 samples in the control group were observed positive (12.5%)
(Table 1). Statistical analysis by Chi-square test generated a value
of 10.687 with 1 degree of freedom. The two-tailed P value was
equal to 0.0008; the association was thus found very significant.
A MAP specific gene was identified by comparisons between the
MAP genome [12] and the repertoire of human genes by using
NCBI/BLAST. After BLAST -P analysis, we identified MAP2694
to share sequence homology to the T-cell receptor gamma chain C
region (Figure 1A, Aa region 257–319) and also to the
complement component 1 (Figure 1B, Aa region 225–331).
Figure 2. Computational prediction of the MAP2694 structure and properties such as different helices and turns, hydrophobicity,
antigenicity and surface probability, etc. using Protean software from the DNAstar package (DNAstar Inc., Madison, USA). In the
inset is the highlighted antigenic index value which corresponded to the homology between MAP2964 (Aa 301-209) and T-cell receptor gamma/
complement component 1.
doi:10.1371/journal.pone.0018482.g002
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DNAStar program is shown in Figure 2. The values indicating
antigenic index, hydrophilicity and surface probability are are seen
therein. A possibly significant epitope (max antigenic index 3.4)
was identified and highlighted on the image between amino acids
301–309. It is located within the homology between MAP2964
and T cell receptor gamma chain/complement component 1 of
the host and it has a high probability to be exposed on the surface
of the membrane (max 2.39).
In view of these putative homologies, it is noteworthy that the cd
T cells have the potential to influence all levels of inflammation
through rapid production of inflammatory mediators, recruitment
of inflammatory cells via chemokines, influencing T cell differenti-
ation by cytokine production, and/or direct killing via production of
cytotoxic mediators [2,13]. Many data suggest that cd T cells play a
pathogenic role in CNS inflammation and autoimmunity [2,13].
Complement activation is known to occur in (white matter) MS
lesions. It is thought to mediate oligodendrocyte/myelin damage
and to be a marker of pathologic heterogeneity among individuals
[14]. Deposition of the complement activation product, C1q was
detected on and within macrophages/microglia and astrocytes and
in blood vessel walls in (white matter) MS lesions [14].
These observations led us further to design immunoassays for
the detection of anti-MAP antibodies in this group of patients. The
Figure 3. Evaluation of serum samples against MAP2694 recombinant protein. MS patients sera are shown in the left column whereas
Healthy Controls sera are shown in the right column. Data are presented as OD values observed in ELISA, as also described in the text. Data from a
representative experiment out of three are shown. The mean value for each group is indicated by a thick horizontal line. IS900 PCR positive samples
are indicated as black solid figures.
doi:10.1371/journal.pone.0018482.g003
Figure 4. AUC-ROC Test. Evaluation of serum samples from 50 MS
patients (right column) and 56 healthy controls (left column) against
MAP2694 recombinant protein by the AUC-ROC test. The horizontal
blue line highlights the cut-off value(s) which gives a specificity of 25%.
Data are presented as OD values observed in ELISA. Area under curve
(AUC)=0,686; P=0,0003.
doi:10.1371/journal.pone.0018482.g004
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MS patients and only in 2% of the controls (chi=16.04;
P,0.0001) (Figure 3 and Table 1). Such extremely significant
humoral responses to the recombinant MAP2694 corroborated
with and strengthened our initial hypothesis. The performance of
ELISA test was also assessed by the area under the receiver
operating characteristic curve (AUC-ROC) (Figure 4) where the
best cut off value is indicated at 0.784 with a sensitivity of 42% and
an extremely statistically significant P value of 0.0003. It is
interesting to observe that both the patients with primary
progressive disease were simultaneously positive to PCR as well
as ELISA whereas, among the 6 patients with secondary
progressive disease, one was positive to both PCR and ELISA,
three were positive only to PCR, and 2 were negative to both the
tests.
Discussion
Several studies have suggested that different pathogens could
trigger an autoimmune response by immunological cross-reactivity
or molecular mimicry [15]. Sardinia acts as an ideal setting for MS
studies because the prevalence of MS in the region is perhaps the
highest observed in the world. Epidemiological evidences support
the idea that the gene pool of Sardinians has been subjected to
selective pressures during the history, but dramatically high
incidence of MS in Sardinia could not be explained only by
genetic predisposition; this necessitates search for a strong
environmental trigger also.
Our finding of MAP PCR positivity in 42% of the MS patients
and its corroboration with the humoral responses observed against
MAP2694 protein, homologue of a c T-cell receptor and the
complement component 1 of the host, appears to be a potential
start point to gain more in depth mechanistic insights in to the
development of MS and other autoimmune diseases which are
supposedly under the regulatory control of an environmental
trigger to induce autoimmunity. However, not all of our healthy
controls were negative for the presence of MAP. But, as previously
found [3,4,6,9,10], a low percentage of healthy controls gave a
positive test for MAP pointing to the possibility that the patient
population might have been exposed to MAP and depending on
individual genetic susceptibility, the infection may be contained or
may have progressed to a chronic autoimmune stage. In contrast
with the previous findings [16], we found a poor correlation
between PCR results and serological response to MAP antigens.
We suggest that ELISA positivity may follow different patterns
than PCR positivity due to the immunological statuses of the
patients which might possibly be anergic or have an altered
immune response. It is interesting to observe that PCR was
positive in the two cases of primary progressive disease and in 4
out of 6 cases of secondary progressive disease.
Homology of the MAP2694 to the T-cell receptor c chain and
the complement component 1 is an important observation which is
potentially suggestive of an underlying molecular mimicry.
cd T cells are a family of cells which have a role in both innate and
adaptive immunity [2,13]. The fact that they are commonly known for
their response to mycobacterium and their locations at mucosal sites is
very intriguing in light of our results. cd T cells have been located in the
CSF and in lesions of MS patients and clearly they seem to have a role
in the regulation of autoimmune inflammation in the CNS and in
other similar disorders such as diabetes and arthritis [17,18].
Kobayashi et al [19] administered T-cell receptor (TCR) cd -
specific monoclonal antibody (mAb),UC7-13D5, to elucidate the
potential role of cd T-cells in the pathogenesis of experimental,
allergic encephalomyelitis (EAE) in mice. mAb treatment led to
transient depletion of the cd– T cells in vivo. mAb-treated EAE
mice showed an acceleration of the disease onset, as well as
relapse, and, also increased Ag-specific proliferative responses
compared to control mice implying a protective function of T cells
[18]. This may be suggestive of a mechanism where antibodies
raised against MAP2964 may cross react as depleting antibodies
against cd T-cells which in turn accelerate the disease. This has led
us to speculate that MAP infection (or other mycobacteria) could
be central to the pathogenesis of MS. The fact that we have
previously found relevant NRAMP1 polymorphisms in Crohn’s
patients [6], T1DM patients [4] and MS patients [5], together
with the positive results given by IS900 PCR, suggests that there is
a strong possibility of MAP being involved with autoimmune
responses in MS just in the same manner as it did in Crohn’s and
T1DM.
In conclusion, these first and potentially relevant observations
reinforce our preliminary hypothesis that MAP could be one of the
triggers of MS (conforming to the molecular mimicry theory) in
susceptible (and genetically at risk) individuals [15]. This finding
might stimulate further studies to verify our pilot observations and
open new frontiers for the investigation of pathogenesis of MS,
including the possibility to develop new intervention strategies.
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